Cerebras Systems had a dramatic debut. The AI chip maker went public last month and its stock shot past $300 almost immediately. Then it came back down to earth.
CBRS was trading around $211.80 in premarket on Monday, up about 5.4% on the day, but still well off those early highs. The previous week saw a 6.7% drop as the broader semiconductor sector sold off.
Now, a wave of analyst initiations is landing — and Wall Street thinks there’s a case to be made at the current price.
Mizuho’s Vijay Rakesh kicked things off with an Outperform rating and a $300 price target. Wedbush’s Matt Bryson followed with a Buy and a $270 target. Barclays set an overweight rating with a $280 target. UBS and Rosenblatt both came in at $300. Morgan Stanley was the most conservative of the group, initiating at overweight with a $250 target.
That’s a lot of green lights from the Street in one morning.
The core of the bull case is the chip itself. Cerebras builds what’s called a Wafer-Scale Engine — essentially the largest chip ever commercially sold. It’s engineered specifically for AI inference, the process of running a trained model to generate outputs.
Unlike Nvidia’s approach, which links thousands of smaller GPUs together through complex networking, Cerebras puts everything on one massive chip. That cuts out a lot of the overhead and delivers faster token generation.
“With the industry focused on inference to deliver Agentic AI solutions, we see Cerebras well-positioned as the industry leader in fast inference,” Mizuho’s Rakesh wrote.
Wedbush described the architecture as differentiated and noted that the market is “now learning to pay for speed” in AI inference.
Cerebras reported a revenue backlog of $24.6 billion as of the end of 2025. That number turns heads. But there’s a catch: the bulk of it comes from a single deal with OpenAI.
That concentration has given some investors pause. However, the company also has a contract with Amazon Web Services, which adds at least one more major name to the client list and offers some comfort around diversification.
Wedbush’s Bryson framed it this way: “With a differentiated architecture, a step-change in contracted revenue from OpenAI and AWS, and a market only now learning to pay for speed, we see an asymmetric, upside-skewed setup.”
His $270 target is based on 40 times his estimate for 2028 earnings, plus net cash.
Revenue over the last twelve months came in at $510 million, up 76% year-over-year. The stock trades at 225x earnings, which InvestingPro flagged as above fair value.
At Monday’s premarket price of around $211, CBRS was up roughly 14% on the session by mid-morning, according to updated data.
The post Cerebras (CBRS) Stock Dropped 30% From Its IPO High. Wall Street Just Said Buy. appeared first on CoinCentral.
